Abstract

Alpha-thalassemia is the most common inherited disorder of hemoglobin synthesis. Genomic deletions involving the alpha-globin gene cluster on chromosome 16p13.3 are the most frequent molecular causes of the disease. Although common deletions can be detected by a single multiplex gap-PCR, the rare and novel deletions depend on more laborious techniques for their identification. The multiplex ligation-dependent probe amplification (MLPA) technique has recently been used for this purpose and was successfully used in the present study to detect the molecular alterations responsible for the alpha-thalassemic phenotypes in 8 unrelated individuals (3 males and 5 females; age, 4 months to 30 years) in whom the molecular basis of the disease could not be determined by conventional methods. A total of 44 probe pairs were used for MLPA, covering approximately 800 kb from the telomere to the MSLN gene in the 16p13.3 region. Eight deletions were detected. Four of these varied in size from 240 to 720 kb and affected a large region including the entire alpha-globin gene cluster and its upstream regulatory element (alpha-MRE), while the other four varied in size from 0.4 to 100 kb and were limited to a region containing this element. This study is the first in Brazil to use the MLPA method to determine the molecular basis of alpha-thalassemia. The variety of rearrangements identified highlights the need to investigate all cases presenting microcytosis and hypochromia, but without iron deficiency or elevated hemoglobin A₂ levels and suggests that these rearrangements may be more frequent in our population than previously estimated.

Highlights

  • The human alpha (α)-globin gene cluster is located on the distal portion (p13.3-pter) of the short arm of chromosome 16 and includes three functional α-like protein coding genes (ζ, α2, and α1), two expressed genes with unknown function (μ and θ1), and three pseudogenes arranged in the order 5’-ζ-ψζ- μ- ψα1- α2- α1- ψρ- θ1-3’ [1,2]

  • Molecular lesions affecting the α-globin genes or their regulatory element (α-MRE) lead to α-thalassemia, an inherited hemoglobin (Hb) disorder characterized by a reduction in or absence of α-globin chain synthesis

  • Patient 1 (P1) showed a deletion limited to a region containing the upstream regulatory element HS40

Read more

Summary

Introduction

The human alpha (α)-globin gene cluster is located on the distal portion (p13.3-pter) of the short arm of chromosome 16 and includes three functional α-like protein coding genes (ζ, α2, and α1), two expressed genes with unknown function (μ and θ1), and three pseudogenes (ψζ, ψα, ψρ) arranged in the order 5’-ζ-ψζ- μ- ψα1- α2- α1- ψρ- θ1-3’ [1,2]. The α-globin regulatory elements lie upstream of the start of the ζ-globin gene (10 to 50 kb) and consist of four conserved DnaseI hypersensitive sites (HS-48, HS-40, HS-33, and HS-10) that bind erythroid-specific transcription factors [3,4]. Of these four sites, HS-40 is the only one capable of directing high-level expression of the α-globin chains and is the major regulatory element (α-MRE) [5]. Molecular lesions affecting the α-globin genes or their regulatory element (α-MRE) lead to α-thalassemia, an inherited hemoglobin (Hb) disorder characterized by a reduction in or absence of α-globin chain synthesis. Carriers of three functioning globin genes (-α/αα) do not present detectable red blood cell abnormalities or globin-chain imbalance, while carriers of two functioning

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call